Boere W A, Benaissa-Trouw B J, Harmsen M, Kraaijeveld C A, Snippe H
J Gen Virol. 1983 Jun;64 (Pt 6):1405-8. doi: 10.1099/0022-1317-64-6-1405.
Two monoclonal antibodies (UM 4.2 and UM 5.1) directed against the glycoprotein E2 of Semliki Forest virus (SFV) are described; both belong to the IgG2a isotype but are of different idiotype. Analysis employing isoelectric focusing resulted in different focusing patterns for both monoclonals (UM 4.2, pI 8; UM 5.1, pI 7.2). They further differed in their ability to neutralize virus. The UM 4.2 antibodies were inactive in neutralization, while the UM 5.1 antibodies exceeded conventional mouse hyperimmune serum in this respect. Both monoclonal antibodies, however, were able to protect mice passively from a lethal infection with SFV. Based on the amount of protein, the UM 5.1 antibodies were 100-fold more effective than the UM 4.2 antibodies in mouse protection tests.
描述了两种针对塞姆利基森林病毒(SFV)糖蛋白E2的单克隆抗体(UM 4.2和UM 5.1);二者均属于IgG2a同种型,但独特型不同。采用等电聚焦分析得出两种单克隆抗体(UM 4.2,pI 8;UM 5.1,pI 7.2)的聚焦模式不同。它们在中和病毒的能力上也存在差异。UM 4.2抗体无中和活性,而UM 5.1抗体在这方面超过了传统的小鼠超免疫血清。然而,两种单克隆抗体都能够被动保护小鼠免受SFV致死性感染。在小鼠保护试验中,基于蛋白量,UM 5.1抗体在保护小鼠方面比UM 4.2抗体有效100倍。